Stem Cell Therapy Market Key Players and Opportunities by 2031

The stem cell therapy market size is projected to reach US$ 8.9 billion by 2031 from US$ 3.5 billion in 2023. The market is expected to register a CAGR of 8.7% during 2023–2031. Research activities and product innovations are likely to remain key trends in the market.

Stem Cell Therapy Market Analysis

Research activities and product innovations are likely to remain key trends in the market. A report by EuroGCT reveals that blood stem cell transplant proves effective to treat blood cancer types such as leukaemia, lymphoma, and myeloma; myelodysplastic syndrome; and myeloproliferative disorders. Additionally, blood stem cell transplants clinically proven to treat Severe Combined Immunodeficiency (SCID) by replacing faulty immune cells with healthy donor cells. Therefore, research activities and product innovation is an influential factor responsible to account considerable market growth during 2021-2031.

Stem Cell Therapy Market Overview

Increasing funding or investment will enhance stem cell research. In 2023, the  Hong Kong-based Lee Shau Kee Foundation to the University's Institute for Regeneration and Repair (IRR) received US$ 10.82 million to boost the University's stem cell research and tissue engineering. The fund will support the international collaboration program in stem cell biology that will help the IRR work to address diseases such as chronic organ dysfunction, trauma, and congenital and genetic conditions. Therefore, rising funding or investment will accelerate demand for stem cell therapy in the coming decade.

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Stem Cell Therapy Market: Strategic Insights

Stem Cell Therapy Market Drivers and Opportunities

Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management to Favor Market

Stem cell therapy has been widely investigated globally as stem cells are mainly used to replace dying cells and reconstruct damaged tissues. Based on the clinical results by the scientists conducted targeting stem cell, claims that these cells could probably be utilized to generate specific treatments for several diseases such as cancer and cardiovascular disease. Additionally, developed stem cell therapies involve replacing disease-causing cells with stem cells. Researchers are further investigating the use of stem cell therapy to treat autoimmune disorders. Therefore, increasing research activities related to stem cell therapy for effective disease management is one of the major drivers for global stem cell therapy market share.

Use of Induced Pluripotent Stem Cells in Regenerative Medicines Provide Lucrative Market Opportunity

According to the Frontiers Media S.A. 2023 report, progress in the field of induced pluripotent stem cells (iPSCs) has opened new channel for research in therapeutics. iPSCs are mainly intended for research and clinical studies for disease modelling, regenerative medicine, and drug discovery/drug cytotoxicity studies. For example, iPSCs can be used to convert differentiated somatic cells to multipotent stem cells to generate different cell types of adult tissues. Therefore, iPSCs have shown promising results in regenerative medicine, particularly for replacing diseased or injured cells. Therefore, studies such as drug discovery involving screening of small molecules and toxicity testing for safety assessment have been successfully disclosed positive iPSCs-based results is likely to create lucrative opportunities for the stem cell therapy market players in the coming years.

Stem Cell Therapy Market Report Segmentation Analysis

Key segments that contributed to the derivation of the stem cell therapy market analysis are type, treatment, application, and end user.

• Based on type, the stem cell therapy market is segmented as adult stem cell therapy, embryonic stem cell therapy, induced pluripotent stem cell therapy, and other stem cell therapy. The adult stem cell therapy segment held a larger market share in 2023.
• By treatment, the market is bifurcated into allogeneic and autologous. The allogeneic segment held the largest share of the market in 2023.
• By application, the market is segmented into musculoskeletal, dermatology, cardiology, drug discovery and development, and other applications. The drug discovery and development segment held the largest share of the market in 2023.
• By end user, the market is segmented into hospitals & specialty clinics and academic & research institutes. The academic & research institutes segment held the largest share of the market in 2023.

Stem Cell Therapy Market Share Analysis by Geography

The geographic scope of the Stem Cell Therapy market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the market. In North America region, the US accounts largest share for stem cell therapy market. Presence of top manufacturers in the region and high research and development (R&D) activities are the factors contributing to the dominance of the market. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.

Stem Cell Therapy Market Regional Insights

The regional trends and factors influencing the Stem Cell Therapy Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Stem Cell Therapy Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Stem Cell Therapy Market Report Scope

Stem Cell Therapy Market Players Density: Understanding Its Impact on Business Dynamics

The Stem Cell Therapy Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Stem Cell Therapy Market News and Recent Developments

The Stem Cell Therapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the stem cell therapy market are listed below:

• Allogene Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to “ALLO-605”. The newly granted product is the company’s next-generation AlloCAR T therapy for the treatment of relapsed or refractory multiple myeloma. The FDA granted Fast Track designation based on the potential of ALLO-605 to address the unmet need for patients who have failed other standard multiple myeloma therapies. (Source: Allogene Therapeutics, Inc., Company Website, June 2021)

Stem Cell Therapy Market Report Coverage and Deliverables

The “Stem Cell Therapy Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Stem cell therapy market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Stem cell therapy market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Stem cell therapy market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Stem Cell Therapy market
• Detailed company profiles